$1.50
-0.05-3.23%
At close: Jun 5, 5:00 PM EST
$1.55
0.053.33%
After Hours: Jun 5, 9:28 AM EST
Cardiff Oncology Inc Earnings Estimates
CRDFNASDAQ
Cardiff Oncology Earnings Estimates, EPS & Revenue | NASDAQ:CRDF
Cardiff Oncology (CRDF) is scheduled to report Q2 earnings on July 28, 2026. Analysts estimate EPS of $-0.16 and quarterly revenue of $68.22K.
In the most recent quarter (Q1), Cardiff Oncology reported EPS of $-0.18, missing estimates of $-0.13 by 0.38%. Revenue came in at $41.00K, missing the estimate of $90.00K by 0.54%.
Over the last 4 quarters, Cardiff Oncology has averaged an EPS surprise of 0.27% and a revenue surprise of 0.45%.
Earnings Date
Jul 28
EPS Estimate
$-0.160
Quarterly Revenue Estimate
$68.22K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$525.00K
Cardiff Oncology Earnings History
Analyze the earnings history of Cardiff Oncology using advanced sorting and filters.
Loading calendar...
Cardiff Oncology (CRDF) Earnings Per Share
The chart below shows Cardiff Oncology's reported EPS compared to analyst estimates over recent quarters.
Cardiff Oncology (CRDF) Revenue
The chart below shows Cardiff Oncology's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Cardiff Oncology (NASDAQ:CRDF) reporting earnings?
Cardiff Oncology (CRDF) is scheduled to report earnings on July 28, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for Cardiff Oncology (NASDAQ:CRDF)?
The Actual EPS was $-0.18, which missed the estimate of $-0.13.
What were Cardiff Oncology’s (NASDAQ:CRDF) revenues?
The Actual Revenue was $41.00K, which missed the estimate of $90.00K.
